PWMG
ABBV icon

Provence Wealth Management Group’s AbbVie ABBV Stock Holding History

Provence Wealth Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$605K Buy
3,907
+331
+9% +$48.3K 0.33% 68
2023
Q3 		$533K Buy
3,576
+805
+29% +$118K 0.33% 67
2023
Q2 		$373K Sell
2,771
-1,149
-29% -$168K 0.22% 88
2023
Q1 		$625K Buy
3,920
+1,717
+78% +$263K 0.42% 54
2022
Q4 		$356K Buy
+2,203
New +$338K 0.29% 74

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Provence Wealth Management Group's ABBV Position: Q4 2023 in Review

Provence Wealth Management Group increased its AbbVie (ABBV) stake by 9.3% in Q4 2023, buying an estimated $48.3K and bringing the position to 3,907 shares worth $605K. The position accounts for 0.33% of the portfolio, ranked #68.

Provence Wealth Management Group first reported a position in ABBV in Q4 2022 and has held it in 5 quarters since. The position peaked at $625K in Q1 2023. 3,324 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

  • Provence Wealth Management Group held 3,907 shares of AbbVie worth $605K as of Q4 2023.
  • Provence Wealth Management Group bought 331 AbbVie shares in Q4 2023, an estimated $48.3K.
  • AbbVie made up 0.33% of Provence Wealth Management Group's portfolio in Q4 2023, its #68 holding.
  • Provence Wealth Management Group first reported a position in AbbVie in Q4 2022 and has held it in 5 quarters since.
  • Provence Wealth Management Group's AbbVie position peaked at $625K in Q1 2023.
  • 3,324 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on Provence Wealth Management Group's 13F filing for Q4 2023, filed 6 Feb 2024.